A light shining through darkness: probiotic against COVID-19
Journal of Current Biomedical Reports · 2020
DOI: 10.52547/jcbior.1.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Biomedical Reports, 2020. Verfasst von Meysam Hasannejad-Bibalan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
The colonic microbiota play a key role in human gastrointestinal tract physiology include maintaining homeostasis of the large bowel and modulating the host immune response. Lactic acid bacteria (LAB) especially Lactobacillus and Bifidobacterium are the main part of gut microbiota, which are considered as health beneficial probiotic bacteria with valuable effects in humans [1, 2]. Probiotic bacteria are currently used in industrial food production and therapeutically procedures [3]. The lactic acid produced by probiotic bacteria in the fermentation process causes decrease pH to inhibit the growth of putrefactive and pathogenic bacteria. Besides, LAB could have improvement effects on the nutritional value of fermented products through increase the production of the main food components such as vitamins, essential minerals, and amino acids [4]. Probiotics have been shown to be effective in preventing and treating different disorders such as atopic dermatitis, urinary tract-
Zitieren
APA
Hasannejad-Bibalan, M., & Hekmatnezhad, H. (2020). A light shining through darkness: probiotic against COVID-19. Journal of Current Biomedical Reports. https://doi.org/10.52547/jcbior.1.1.1
Vancouver
Hasannejad-Bibalan M, Hekmatnezhad H. A light shining through darkness: probiotic against COVID-19. Journal of Current Biomedical Reports. 2020. doi:10.52547/jcbior.1.1.1
BibTeX
@article{HasannejadBibalan2020,
author = {Hasannejad-Bibalan, Meysam and Hekmatnezhad, Hamed},
title = {A light shining through darkness: probiotic against COVID-19},
journal = {Journal of Current Biomedical Reports},
year = {2020},
doi = {10.52547/jcbior.1.1.1}
}
EUVIMED